Better prosthetic limb control from MIT researchers
MIT researchers have shown that they can accurately track muscle movement using tiny magnetic beads implanted in the muscle. These measurements could make it easier for people with… read more.
MIT researchers have shown that they can accurately track muscle movement using tiny magnetic beads implanted in the muscle. These measurements could make it easier for people with… read more.
Emergency Medicine & Intensive Care
The label “corridor care” is hiding the true scale of the NHS hospital crisis, warns a senior doctor in The BMJ today. Corridor care refers to the practice… read more.
Endocrinologists who scored highest on the American Board of Internal Medicine’s Longitudinal Knowledge Assessment (LKA®) were more likely to prescribe a key diabetes drug class following a treatment… read more.
Teva Pharmaceuticals announced that the FDA has approved Weltruza (olanzapine) for extended-release injectable suspension, a new, once-monthly, subcutaneous long-acting injectable (LAI) for the treatment of schizophrenia in adults…. read more.
NICE has updated its managed access recommendation for exa-cel to include children aged 5 to 11 years, following the MHRA’s extension of the UK marketing authorisation on 29… read more.
For decades, patients had a family doctor who knew them, their parents and their medical history, but this backbone of British general practice has collapsed, GPs warn, to… read more.
Eli Lilly and Company announced that the FDA has approved an additional indication for Jaypirca (pirtobrutinib, 100 mg & 50 mg tablets), a non-covalent Bruton tyrosine kinase (BTK) inhibitor,… read more.
Medtronic plc announced primary endpoint results from the SPYRAL AFFIRM post-approval study of the Symplicity Spyral renal denervation (RDN) system. The study showed statistically significant and clinically meaningful… read more.
INOVIO announced that the FDA has granted accelerated approval for VOCERYQ (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd), previously referred to as INO-3107, to reduce the frequency of surgery in adults with RRP…. read more.
Pfizer Inc. announced that the FDA has expanded approval of Talzenna (talazoparib) in combination with Xtandi (enzalutamide) to the treatment of men with metastatic androgen pathway modulation-naïve or… read more.
Investigators have developed and validated a clinical decision support tool to improve the diagnosis and treatment of chronic kidney disease (CKD) at the point of care. The research… read more.
An updated Cochrane review has found that ergonomic interventions show no meaningful benefit for pain, function, recovery or sick leave in workers with work-related complaints of the arm,… read more.